Clinical Trial

Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test the drug PT150, which blocks glucocorticoid receptor (GR) signaling, for treatment of PTSD in Veterans, and establish a safety and efficacy profile that will inform the design of future studies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-15.
Trial Details
NCT Number NCT07187011
Lead Sponsor San Diego Veterans Healthcare System
Collaborators: United States Department of Defense, Pop Test Oncology LLC
Conditions PTSD - Post Traumatic Stress Disorder
Enrollment 120 participants
Start Date 2026-04-01
Primary Completion 2029-03-01 (estimated)
Study Completion 2029-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-23